Alvotech Issues New Shares to Holders of Convertible Bonds
Alvotech Issues New Shares to Holders of Convertible Bonds
REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued new shares to holders of subordinated convertible bonds, originally issued by Alvotech on November 16, 2022, and December 20, 2022, with maturity on December 20, 2025 (the "Convertible Bonds").
冰岛雷克雅未克，2024年7月1日（环球新闻专线）——专门为全球患者开发和制造生物仿制药的全球生物技术公司Alvotech（纳斯达克股票代码：ALVO）今天向次级可转换债券的持有人发行了新股，该债券最初由Alvotech于2022年11月16日和2022年12月20日发行，到期日为2025年12月20日（“可转换债券”）。
Today, Alvotech issued 22,073,578 new ordinary shares in exchange for Convertible Bonds, at the fixed price of US$10.00 per share. The majority of the holders of Convertible Bonds exercising their conversion right, are existing shareholders in Alvotech.
今天，Alvotech发行了22,073,578股新的普通股以换取可转换债券，固定价格为每股10.00美元。行使转换权的可转换债券的大多数持有人是Alvotech的现有股东。
Following the conversion of the Convertible Bonds into shares, the total number of issued shares in Alvotech is 324,801,040 and the total number of outstanding shares is 301,944,470. Pursuant to terms of the Convertible Bonds, the newly issued shares shall be delivered to their owners no later than seven business days from today.
将可转换债券转换为股票后，Alvotech的已发行股票总数为324,801,040股，已发行股票总数为301,944,470股。根据可转换债券的条款，新发行的股票应在今天起的七个工作日内交付给其所有者。